Matthew W. Foehr, President and COO at LIGAND PHARMACEUTICALS INC (LGND), bought 2,500 shares at $82.76 ($207K) on 2022-05-13, disclosed to the SEC on 2022-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OABI | SELL | 2026-02-17 | $35K | — | Filing → |
| VKTX | SELL | 2026-01-05 | $1.1M | — | Filing → |
| OABI | SELL | 2025-12-09 | $27K | — | Filing → |